Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 42051-42100 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05687149
Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
N/ARecruiting
200 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2035
2 conditions1 sponsor1 location
NCT05552443
A Study of Intrathecal Hydromorphone for Pediatric Idiopathic Scoliosis Repair
PHASE4Recruiting
40 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05709288
Gene Therapy for Hemophilia B Patients Aged 12-18 Years Old
PHASE1Recruiting
9 participants
Started: Mar 23, 2023 · Completed: Nov 30, 2035
1 condition1 sponsor1 location
NCT05819476
Boosting Open-Label Placebo Effects in Acute Induced Pain in Healthy Adults
NARecruiting
141 participants
Started: Mar 23, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05626114
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
PHASE2Recruiting
60 participants
Started: Mar 23, 2023 · Completed: Mar 1, 2031
1 condition1 sponsor15 locations
NCT05440708
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
PHASE1/PHASE2Recruiting
178 participants
Started: Mar 23, 2023 · Completed: Jun 28, 2027
1 condition1 sponsor21 locations
NCT05767047
A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
PHASE3Recruiting
48 participants
Started: Mar 23, 2023 · Completed: Mar 17, 2036
2 conditions1 sponsor7 locations
NCT05786040
Tafasitamab and Rituximab for Front-Line Treatment of Post-Transplant Lymphoproliferative Disorder
PHASE2Recruiting
28 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor3 locations
NCT05651828
Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma
EARLY_PHASE1Recruiting
34 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2029
1 condition2 sponsors1 location
NCT06760221
Safety and Efficacy of Preoperative SBRT and Radical Surgery for Soft Tissue Sarcoma of Extremities
NARecruiting
20 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2029
3 conditions2 sponsors1 location
NCT06040203
Leukocyte-rich PRP or Leukocyte-free PRP vs Placebo in the Treatment of Epicondylitis
NARecruiting
240 participants
Started: Mar 23, 2023 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT05652868
Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer
PHASE1Recruiting
250 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2027
7 conditions1 sponsor55 locations
NCT05413551
Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis Prevention
PHASE1Recruiting
72 participants
Started: Mar 23, 2023 · Completed: Oct 31, 2025
2 conditions4 sponsors1 location
NCT05778253
The Role of ctDNA Testing Plus AI-based Pathology in Resectable LSCC
N/ARecruiting
50 participants
Started: Mar 23, 2023 · Completed: Sep 23, 2029
1 condition2 sponsors1 location
NCT05781074
Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer (CASTLE-08)
PHASE2Recruiting
25 participants
Started: Mar 23, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05735379
Impact in Older Adults of Reducing Anticholinergic and Sedative Rx Burden on Physical Function Measured by Wearables
PHASE4Recruiting
182 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05317000
5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC
PHASE2Recruiting
50 participants
Started: Mar 23, 2023 · Completed: Feb 28, 2027
1 condition2 sponsors1 location
NCT05633875
Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple Sclerosis
N/ARecruiting
80 participants
Started: Mar 23, 2023 · Completed: Apr 25, 2025
1 condition1 sponsor1 location
NCT05765864
Self-harm Behaviour Among the Most At-risk Adolescents
N/ARecruiting
400 participants
Started: Mar 23, 2023 · Completed: Oct 31, 2025
6 conditions4 sponsors2 locations
NCT06056362
Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors
PHASE1/PHASE2Recruiting
80 participants
Started: Mar 23, 2023 · Completed: Mar 27, 2025
1 condition1 sponsor1 location
NCT05649852
Anxiolytic Effects of Socio-aesthetics in Cancer Patients Undergoing Chemotherapy
NARecruiting
192 participants
Started: Mar 23, 2023 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT06058637
ISCREEN-study: Online Nurse-assisted Eye-screening in Home Healthcare
NARecruiting
220 participants
Started: Mar 23, 2023 · Completed: Oct 1, 2025
1 condition3 sponsors1 location
NCT05719415
Functional Pulmonary Capillary Surface Area in BPA for CTEPH
NARecruiting
40 participants
Started: Mar 23, 2023 · Completed: Jan 30, 2028
2 conditions1 sponsor1 location
NCT05744596
Assessment of the Role of Incisura Biopsy in the Staging of Chronic Gastritis
N/ARecruiting
400 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05625958
Clinical Study Evaluating the Efficacy and Safety of CID v2.2 in Glaucoma Surgery
NARecruiting
29 participants
Started: Mar 23, 2023 · Completed: Sep 1, 2028
2 conditions1 sponsor6 locations
NCT06068647
Ultrasound and Respiratory Physiological Signals in Lung Diseases
NARecruiting
25 participants
Started: Mar 22, 2023 · Completed: Mar 31, 2026
8 conditions2 sponsors1 location
NCT05723432
KD6001 in Combination With Anti-PD-1 Antibody in Patients With Advanced Melanoma
PHASE1/PHASE2Recruiting
84 participants
Started: Mar 22, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04949464
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
NARecruiting
100 participants
Started: Mar 22, 2023 · Completed: Dec 26, 2026
2 conditions2 sponsors11 locations
NCT05275218
Effect of an Intervention to Prevent Acute Kidney Injury Versus Standard Care in High-risk Patients After Major Surgery
NARecruiting
480 participants
Started: Mar 22, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05832177
Outreach Core Activities
N/ARecruiting
1,200 participants
Started: Mar 22, 2023 · Completed: Jul 31, 2028
2 conditions2 sponsors2 locations
NCT05596539
Prospective, Longitudinal, Observational Registry of Adult Patients with Hypophosphatasia (REG-HYPO)
N/ARecruiting
100 participants
Started: Mar 22, 2023 · Completed: Mar 31, 2031
1 condition1 sponsor10 locations
NCT05569122
Applying pGz in Mitochondrial Disease
PHASE1Recruiting
90 participants
Started: Mar 22, 2023 · Completed: Oct 31, 2025
2 conditions2 sponsors1 location
NCT05823285
A Study Evaluates the Safety, Pharmacokinetics, Immunogenicity and Efficacy of QLS31903 in Advanced Solid Tumor Patients
PHASE1Recruiting
150 participants
Started: Mar 22, 2023 · Completed: Jun 15, 2027
1 condition1 sponsor1 location
NCT05763290
Childhood Cancer Survivors' Affective Response to Exercise
N/ARecruiting
125 participants
Started: Mar 22, 2023 · Completed: Feb 28, 2030
2 conditions1 sponsor1 location
NCT06800105
Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study
N/ARecruiting
10 participants
Started: Mar 22, 2023 · Completed: Mar 31, 2028
1 condition1 sponsor1 location
NCT05490134
RM1 Project 1 - tAN Naloxone
EARLY_PHASE1Recruiting
136 participants
Started: Mar 22, 2023 · Completed: Oct 1, 2027
1 condition1 sponsor1 location
NCT05667766
Minimising Adverse Drug Reactions and Verifying Economic Legitimacy in Children (MARVEL-PIC)
NARecruiting
880 participants
Started: Mar 22, 2023 · Completed: Aug 31, 2027
2 conditions1 sponsor4 locations
NCT05566431
Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics
NARecruiting
428 participants
Started: Mar 22, 2023 · Completed: Jan 31, 2028
1 condition2 sponsors11 locations
NCT05791656
Interference Screw Mectascrew-C Postmarket Study
N/ARecruiting
44 participants
Started: Mar 22, 2023 · Completed: Mar 31, 2025
2 conditions1 sponsor1 location
NCT05402657
The RAFT ECT Study
NARecruiting
154 participants
Started: Mar 22, 2023 · Completed: Jan 31, 2026
1 condition10 sponsors7 locations
NCT06251583
Prevention of Incisional Hernia With Mesh-suture at Umbilical Trocar Site.
PHASE3Recruiting
124 participants
Started: Mar 22, 2023 · Completed: Jun 30, 2025
3 conditions14 sponsors1 location
NCT06325059
The Role of Renal Progenitors and Polyploid Tubular Cell Response in Glomerular and Tubular Diseases
NARecruiting
200 participants
Started: Mar 22, 2023 · Completed: Nov 30, 2047
1 condition1 sponsor1 location
NCT05531734
MONITORING OF ATTENTION ACCORDING TO FATIGUE IN THE HEALTHY SUBJECT
NARecruiting
30 participants
Started: Mar 22, 2023 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT05601427
Intra-Operative Adductor Canal Blocks
NARecruiting
80 participants
Started: Mar 22, 2023 · Completed: Jan 31, 2026
4 conditions2 sponsors1 location
NCT05781555
A Study of Diffusing Alpha Radiation Therapy for Target Treatments of Malignant Tumors
NARecruiting
100 participants
Started: Mar 22, 2023 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT05597280
Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy
PHASE3Recruiting
124,000 participants
Started: Mar 22, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05660369
CARv3-TEAM-E T Cells in Glioblastoma
PHASE1Recruiting
21 participants
Started: Mar 22, 2023 · Completed: Jan 1, 2027
4 conditions1 sponsor1 location
NCT06287034
The Role of the Free/Pedunculated Flap in Total Laryngectomy After (Chemo-)Radiotherapy Failure for Laryngeal Carcinoma: Impact on the Risk of Pharyngocutaneous Fistula (PCF)
N/ARecruiting
102 participants
Started: Mar 21, 2023 · Completed: Sep 21, 2025
1 condition1 sponsor1 location
NCT05868616
Non-Invasive Method for Evaluation of Cardiac Resynchronization Therapy
N/ARecruiting
80 participants
Started: Mar 21, 2023 · Completed: Mar 31, 2031
5 conditions3 sponsors1 location
NCT05539937
Prospective Evaluation of the Quality of Life of Elderly Patients Undergoing Transfemoral Percutanous Aortic Valve Replacement (TAVI) for the Treatment of Severe Aortic Stenosis.
N/ARecruiting
140 participants
Started: Mar 21, 2023 · Completed: Mar 31, 2026
3 conditions3 sponsors1 location